Trials / Completed
CompletedNCT06651957
Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)
The Relationship Between Anal High-Risk HPV (Hr-HPV) Infection, Anal High-Grade Squamous Intraepithelial Lesions (HSIL), and the Anal Microbiome Among Three Distinct Populations of Hispanic People Living With HIV (PLWH) in California, Mexico and Puerto Rico
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 217 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The study evaluates if there is relationship between the kinds of bacteria living in the anus (also known as the anal microbiome) and the risk of human papillomavirus (HPV) infection or HPV-related pre-cancer (high-grade squamous intraepithelial lesions or HSIL) in Hispanic people living with HIV (PLWH) in Puerto Rico, Mexico and California
Detailed description
PRIMARY OBJECTIVE: I. Study the relationship between anal high-risk HPV (hr-HPV) infection and the anal microbiome among three distinct populations of Hispanic people living with HIV (PLWH) in Mexico, Puerto Rico, and California. OUTLINE: This is an observational study. Participants undergo collection of 3 anal swab samples, complete questionnaires, and have their medical records reviewed on study. Participants with visible lesions undergo high resolution anoscope with anal biopsy per usual care on study.
Conditions
- Human Immunodeficiency Virus
- Human Papillomavirus-Related Anal Squamous Cell Carcinoma
- High-Grade Squamous Intraepithelial Lesions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Biospecimen Collection | Specimen swabs will be obtained. |
| OTHER | Questionnaires | Given to participants |
Timeline
- Start date
- 2024-10-31
- Primary completion
- 2025-10-31
- Completion
- 2025-10-31
- First posted
- 2024-10-22
- Last updated
- 2025-12-10
Locations
3 sites across 3 countries: United States, Mexico, Puerto Rico
Source: ClinicalTrials.gov record NCT06651957. Inclusion in this directory is not an endorsement.